Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent influenza vaccine multi-dose vial versus single-dose syringe in children
2017-001044-35Phase 3
- Sponsor
- Sanofi
- Start
- Feb 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent influenza vaccine in influenza, sponsored by Sanofi.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2017-001044-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001044-35.